Established since 2015, THERA was created to target the leader position in the local generic market and contract manufacturing. Our strategy is also geared towards the African, European, North American and Middle Eastern markets. With a state-of-the-art equipments, we ensure all processes related to tabletting : wet spray granulation (high shear and fluidized bed granulation), drying, blending, single / bilayer tabletting and coating. With such values as excellence and determination, we are committed to providing the highest quality of medicines to patients. Our site has been designed referring to the most advanced references. Our premises and equipments are fully compliants to the latest technical and regulatory guides (cGMP, FDA, ISO and ISPE). Present in the field of cardiology, endocrinology and oncology, THERA ensures scientific information related to its products is available. Our medical promotion team works in accordance to responsible business practices and is made available to all healthcare professionals.